A PI-led clinical research service
RenuviaMD® Research operates as a Principal-Investigator-led research service, making direct investigator oversight available to partner sites and networks — paired with broad Florida population access and ICH-GCP operations.
Dual-region model
Active coverage in South Florida and Central/West Coast Florida (Tampa Bay, Orlando) — stated as regional PI coverage.
Direct PI oversight
Hands-on investigator leadership across both regions — available to partner sites and not delegated to non-physician staff.
EMR-enabled feasibility
Electronic medical records support efficient feasibility assessment and patient identification within our practice population.
Service mark & identity
- Registered mark
- RenuviaMD® — U.S. Reg. No. 8,203,209, Class 44
- Entity
- RenuviaMD PLLC
- Principal Investigator
- Dr. Armando A. Falcon, MD (FL License ME 84789)
- Operating standard
- ICH-GCP
Coverage is stated as regional PI coverage. No named sites, addresses, or facilities are disclosed publicly. Operational specifics are shared privately with sponsors and CROs under a confidentiality agreement.
Add a qualified PI to your Florida site
Broad population access with credentialed, investigator-led operations.